Transforming US drug access and production: MFN pricing deals and historic manufacturing investments
In November 2025, US President Donald Trump announced transformative actions to lower prescription drug costs and secure the pharmaceutical supply…
Analyst Comment
Pharma M&A deal value up 31% YoY in 2025YTD amid return of mega-deals
Crenolanib delivers incremental benefit in FLT3/NPM1 co-mutated AML
ASH 2025: golcadomide + rituximab combo shows standout potential in R/R FL
Bipolar disorder market to reach $9.4bn across 7MM by 2034
Second round of drug prices negotiated under the IRA revealed
Win for pharma in UK – zero US tariffs, VPAG rate cap and NICE threshold increase
CKD-HPT, HP and HK market to reach $4bn across 7MM by 2034
